XKUC068
Supplement Upper Spine Bursa and Ligament to New Technology Group 8 with Posterior Vertebral Tether, Open Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | X New Technology |
| Body System | K Muscles, Tendons, Bursae and Ligaments |
| Operation | U Supplement |
| Body Part | C Upper Spine Bursa and Ligament |
| Approach | 0 Open |
| Device | 6 Posterior Vertebral Tether |
| Qualifier | 8 New Technology Group 8 |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
This family covers procedures that reinforce or augment a muscle, tendon, bursa, or ligament using an advanced biological or synthetic material, most commonly seen in rotator cuff repair where a bioinductive collagen implant is placed over a repaired or partially torn tendon to encourage the body to grow new, healthier tendon-like tissue in that spot. The tendon or ligament itself is not removed or replaced; the material is added to strengthen an area that is structurally intact but weakened or at risk of re-tearing. This kind of augmentation is typically used alongside a primary repair, giving the existing tissue extra support while it heals and, in some applications, stimulating the growth of new tissue over months. It is often presented to patients as a way to lower the chance of a repair failing or a tear recurring, particularly in tendons subject to ongoing mechanical stress such as the shoulder.
Anatomy & Axis Detail
Upper Spine Bursa and Ligament
The upper spine bursa and ligament complex includes the interspinous and supraspinous ligaments and small bursae of the cervical and upper thoracic vertebrae, structures that stabilize the spine during flexion and help limit excessive motion between adjacent spinous processes. Supplementing this tissue with a new-technology device is generally aimed at reinforcing a segment weakened by degenerative laxity or prior injury without fusing the vertebrae outright, preserving more natural motion than a fusion procedure would. Because these ligaments sit close to the spinal canal and neural elements, precise placement matters both for achieving mechanical support and for avoiding impingement on nearby nerve roots. This approach is typically considered for patients with symptomatic segmental instability who are not ideal candidates for fusion, and documentation should specify the exact vertebral level involved given how much biomechanics differ between cervical and upper thoracic segments.
Approach: Open
Open approach in New Technology denotes access to the target site through a surgical incision that exposes the body part directly to view and instrumentation. It stands apart from percutaneous and endoscopic approaches, which achieve access through small punctures or existing openings rather than a deliberate surgical opening of tissue.
Device / Substance / Technology: Posterior Vertebral Tether
This value describes a flexible tether device attached along the posterior aspect of the vertebral column to gradually guide spinal growth and correct curvature in pediatric scoliosis, functioning as a growth-modulation alternative to spinal fusion. It is distinguished from anterior vertebral body tethering systems by its posterior placement and attachment points. The tether allows continued spinal mobility and growth while progressively straightening the curve.
Qualifier: New Technology Group 8
Group 8 identifies technologies added to the New Technology section for the 2021-2022 update cycle, tying a given code to that specific approval year. The underlying substance, device, or technique is defined by the other six axis positions, not by the group number itself. Because group numbers simply track chronology, Group 8 differs from Group 7 and Group 9 only in when CMS granted the technology separate recognition.
Coding & Documentation
Coders should look for clear documentation that the material was applied to reinforce or augment tissue that remained in place, along with the specific product name, since New Technology Supplement codes are tied to particular devices rather than to augmentation in general. The note should distinguish this step from the underlying repair procedure performed on the same tendon or ligament, as both may be reported together. A frequent error is failing to separately code the augmentation because it is described only as an adjunct in the middle of the repair narrative, or misclassifying it as a Replacement when no tissue was actually removed and replaced.